{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:43:42Z","timestamp":1773276222674,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[1994,5,1]],"date-time":"1994-05-01T00:00:00Z","timestamp":767750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1994,5]]},"DOI":"10.1007\/bf01774544","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T19:31:00Z","timestamp":1119900660000},"page":"S83-S86","source":"Crossref","is-referenced-by-count":2,"title":["Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients \u2014 impact on the immune and other systems"],"prefix":"10.1007","volume":"68","author":[{"given":"M. -C.","family":"Poon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl 1","key":"BF01774544_CR1","first-page":"366a","volume":"80","author":"S Seremetis","year":"1992","unstructured":"Seremetis S, Aledort LM, Bona R et al. (1992) A three-year randomized prospective study of high or intermediate purity factor VIII concentrates in asymptomatic HIV+ hemophiliacs: effects on immune function. Blood 80 [Suppl 1]:366a","journal-title":"Blood"},{"key":"BF01774544_CR2","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood.V78.8.1919.1919","volume":"78","author":"R Biasi De","year":"1992","unstructured":"De Biasi R, Rocino A, Miraglia E, Mastrullo L, Quirino AA (1992) The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate. Blood 78: 1919\u20131922","journal-title":"Blood"},{"key":"BF01774544_CR3","unstructured":"De Biasi R, Rocino A (1992) The impact of very-high-purity, monoclonally purified factor VIII concentrates on the immune system of HIV-positive hemophiliacs. World Federation of Hemophilia Congress Abstracts, p220"},{"key":"BF01774544_CR4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-0038-1648438","volume":"67","author":"PM Mannucci","year":"1992","unstructured":"Mannucci PM, Gringeri A, De Biasi R, Baudo F, Morfini M, Ciavarella N (1992) Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate. Thromb Haemost 67: 310\u2013313","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"BF01774544_CR5","first-page":"230a","volume":"80","author":"PM Mannucci","year":"1992","unstructured":"Mannucci PM, Abildgaard CF, Aledort LM et al. (1992): Immunologic studies in HIV-positive and HIV-negative hemophiliacs receiving recombinant factor VIII (Kogenate) \u2014 a 3-year update. Blood 80 [Suppl 1]:230a","journal-title":"Blood"},{"key":"BF01774544_CR6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0887-7963(92)70155-2","volume":"4","author":"ED Gomperts","year":"1992","unstructured":"Gomperts ED, De Biasi R, De Vreker R (1992) The impact of clotting factor concentrates on the immune system in individuals with hemophilia. Transfu Med Rev 4:44\u201354","journal-title":"Transfu Med Rev"},{"key":"BF01774544_CR7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1136\/jcp.38.10.1163","volume":"38","author":"AC Beddal","year":"1985","unstructured":"Beddal AC, Hill FGH, George RH, Williams MD, Al-Rubei K (1985) Unusually high incidence of tuberculosis among boys with haemophilia during an outbreak of the disease in hospital. J Clin Pathol 38:1163\u20131165","journal-title":"J Clin Pathol"},{"key":"BF01774544_CR8","first-page":"607","volume":"81","author":"DB Brettler","year":"1986","unstructured":"Brettler DB, Forsberg AD, Brewster F, Sullivan JL, Levine PH (1986) Delayed cutaneous hypersensitivity reactions in hemophiliac subjects treated with factor concentrates. Am J Hematol 81:607\u2013611","journal-title":"Am J Hematol"},{"key":"BF01774544_CR9","first-page":"477","volume":"107","author":"MM Lederman","year":"1986","unstructured":"Lederman MM, Saunders C, Toossi Z, Lemon N, Barbara E, Ratnoff OD (1986) Antihemophilic factor (factor VIII) preparations inhibit lymphocyte proliferation and production of interleukin-2. J Lab Clin Med 107:477\u2013478","journal-title":"J Lab Clin Med"},{"key":"BF01774544_CR10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1423-0410.1986.tb00221.x","volume":"51","author":"DS Matheson","year":"1986","unstructured":"Matheson DS, Green BJ, Poon M-C, Bowen TJ, Fritzler MJ, Hoar DI (1986) T-lymphocytes from hemophiliacs proliferate after exposure to factor VIII product. Vox Sang 51:92\u201395","journal-title":"Vox Sang"},{"key":"BF01774544_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0090-1229(87)90050-X","volume":"44","author":"DS Matheson","year":"1987","unstructured":"Matheson DS, Green BJ, Fritzler MJ, Poon M-C, Bowen TJ, Hoar DI (1987) Humoral immune response in patients with hemophilia. Clin Immunol Immunopathol 44:41\u201350","journal-title":"Clin Immunol Immunopathol"},{"key":"BF01774544_CR12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.1989.tb04296.x","volume":"71","author":"R Thorpe","year":"1989","unstructured":"Thorpe R, Dilger P, Dawson NJ, Barrowcliffe TW (1989) Inhibition of interleukin-2 secretion by factor VIII concentrates: a possible cause of immunosuppression in haemophiliacs. Br J Haematol 71:387\u2013391","journal-title":"Br J Haematol"},{"key":"BF01774544_CR13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2141.1990.tb07838.x","volume":"76","author":"R Madhok","year":"1990","unstructured":"Madhok R, Gracie JA, Smith J, Lowe GDO, Forbes CD (1990) Capacity to produce interleukin 2 is impaired in haemophilia in the absence and presence of HIV-1 infection. Br J Haematol 76: 70\u201374","journal-title":"Br J Haematol"},{"key":"BF01774544_CR14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1182\/blood.V67.1.164.164","volume":"67","author":"DS Matheson","year":"1986","unstructured":"Matheson DS, Green GJ, Poon M-C, Fritzler MJ, Hoar DI, Bowen TJ (1986) Natural killer cell activity from hemophiliacs exhibits differential responses to various forms of interferon. Blood 67:164\u2013167","journal-title":"Blood"},{"key":"BF01774544_CR15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2141.1990.tb07841.x","volume":"76","author":"KJ Pasi","year":"1990","unstructured":"Pasi KJ, Hill FGH (1990) In vitro and in vivo inhibition of monocyte phagocytic function by factor VIII concentrates: correlation with concentrate purity. Br J Haematol 76:88\u201393","journal-title":"Br J Haematol"},{"key":"BF01774544_CR16","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1182\/blood.V69.4.1153.1153","volume":"69","author":"MM Eibl","year":"1987","unstructured":"Eibl MM, Ahmad R, Wolf HM, Linnau Y, G\u00f6tz E, Mannhalter JW (1987) A component of factor VIII preparations which can be separated from factor VIII activity down-modulates human monocyte functions. Blood 69:1153\u20131160","journal-title":"Blood"},{"key":"BF01774544_CR17","first-page":"1662","volume":"71","author":"JW Mannhalter","year":"1988","unstructured":"Mannhalter JW, Ahman R, Leibl H, G\u00f6ttlicher J, Wolf HM, Eibl MM (1988) Comparable modulation of human monocyte functions by commercial factor VIII concentrates of varying purity. Br J Haematol 71:1662\u20131668","journal-title":"Br J Haematol"},{"key":"BF01774544_CR18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood.V75.3.810b.810b","volume":"75","author":"JW Mannhalter","year":"1990","unstructured":"Mannhalter JW, Ahman R, Eibl MD, Leibl H (1990) Modulation of human monocyte functions by factor VIII-anti factor VIII complexes present in an affinity-purified factor VIII product. Blood 75:810\u2013811","journal-title":"Blood"},{"key":"BF01774544_CR19","unstructured":"Baxter Healthcare Corporation (1992) Hyland Division: Antihemophilic factor (recombinant) Recombinate. Product Insert"},{"key":"BF01774544_CR20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0887-7963(92)70175-8","volume":"6","author":"E Gomperts","year":"1992","unstructured":"Gomperts E, Lundblad R, Adamson R (1992) The manufacturing process for recombinant factor VIII, Recombinate. Transfus Med Rev 6:247\u2013251","journal-title":"Transfus Med Rev"},{"key":"BF01774544_CR21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.1971.tb03442.x","volume":"21","author":"CRM Prentice","year":"1971","unstructured":"Prentice CRM, Izzat MM, Adams JF, McNicol GP, Douglas AS (1971) Amyloidosis associated with the nephrotic syndrome and transfusion reactions in haemophilia. Br J Haematol 21:305\u2013311","journal-title":"Br J Haematol"},{"key":"BF01774544_CR22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-108-6-797","volume":"108","author":"GH Goldsmith","year":"1988","unstructured":"Goldsmith GH, Baily RG, Brettler DB et al. (1988) Primary pulmonary hypertension in patients with classic hemophilia. Ann Intern Med 108:797\u2013799","journal-title":"Ann Intern Med"},{"key":"BF01774544_CR23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1537-2995.1978.18579036390.x","volume":"18","author":"ME Eyster","year":"1978","unstructured":"Eyster ME, Nau ME (1978) Particulate material in antihemophilic factor (AHF) concentrates. Transfusion 18:567\u2013581","journal-title":"Transfusion"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01774544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01774544\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01774544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T23:42:50Z","timestamp":1586302970000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01774544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,5]]},"references-count":23,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[1994,5]]}},"alternative-id":["BF01774544"],"URL":"https:\/\/doi.org\/10.1007\/bf01774544","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,5]]}}}